FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine. A composition contains a solution of a radioactive fluorine-marked amino acid compound presented by the following formula (1): 
in physiological saline and at least one pharmaceutical additive selected from a group consisting of a pH adjustor, a dilution enhancer, alcohol sugar, sugar and sugar lactone wherein the solution contains no buffers and has the pH value of 2.0-5.9.
EFFECT: composition of the radioactive fluorine-marked amino acid compound is not subject to radiolysis and applicable for tumour detection.
7cl, 1 ex, 8 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION F- FLUTSIKLOVINA IN CITRATE BUFFERS | 2012 |
|
RU2623163C2 |
| STABILISATION OF RADIOPHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2474435C2 |
| ELUENT SOLUTION | 2011 |
|
RU2608932C2 |
| STEREO-SELECTIVE SYNTHESIS OF AMINO ACIDS FOR PRODUCTION OF TUMOR IMAGE | 2006 |
|
RU2376282C2 |
| METHOD OF PRODUCING RADIOACTIVE FLUORINE-LABELLED ORGANIC COMPOUND | 2007 |
|
RU2434846C2 |
| METHOD OF PRODUCING RADIOACTIVE, FLUORINE-LABELLED ORGANIC COMPOUND | 2008 |
|
RU2476423C2 |
| FLUORINATION METHOD FOR SYNTHESIS OF 2-[F]-FLUORO-2-DESOXY-D-GLUCOSE | 2005 |
|
RU2394040C2 |
| METHOD OF RADIOACTIVE LABELING | 2014 |
|
RU2675371C2 |
| OSTEOTROPIC RADIOPHARMACEUTICALS FOR PET IMAGING | 2014 |
|
RU2614235C2 |
| RADIOACTIVE LABELLED PEPTIDES BINDING TO HER2 | 2011 |
|
RU2592685C2 |
